The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Another pharmaceutical company has recalled its Losartan tablets because of the detection of a trace amount of a potential cancer-causing contaminant. Camber Pharmaceuticals, Inc. has recalled 87 lots ...
Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due to the detection of trace amounts of N-Nitroso ...
Macleods Pharmaceuticals is recalling 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide (HCTZ) combination tablets after discovering trace amounts of the potential ...
Thousands of bottles of blood-pressure medicine are being recalled after the Food and Drug Administration said trace amounts of potential carcinogens were found to be in the medicine. Camber ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots ...
Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
The latest domino to fall in the global tainted-sartan debacle is a nationwide recall by Teva Pharmaceuticals of 35 lots of bulk losartan potassium 25 mg and 100 mg USP tablets. The recall, to the ...
Original Advisory (May 30, 2021): Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity Health Canada is informing Canadians that several companies are recalling ...
Uncertainty surrounds the benefit of preventive pharmacological therapies in reducing aortic disease in patients with Marfan syndrome. The Marfan Sartan trial now suggests that losartan is not ...
Original Advisory (May 30, 2021): Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity Health Canada is informing Canadians that several companies are recalling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results